Skip to main content
OMKAR SPECIALITY CHEMICALS LIMITED logo

OMKAR SPECIALITY CHEMICALS LIMITED — Investor Relations & Filings

Ticker · OMKARCHEM ISIN · INE474L01016 LEI · 984500ADAAEB7AG57878 BSE.NS Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS OMKARCHEM

About OMKAR SPECIALITY CHEMICALS LIMITED

http://www.omkarchemicals.com

Omkar Speciality Chemicals Limited is a manufacturer and supplier of specialty chemicals and intermediates. The company specializes in the production of a wide range of inorganic and organic chemicals, with a significant focus on iodine and selenium derivatives. Its product portfolio includes intermediates for Active Pharmaceutical Ingredients (APIs), fine chemicals, and specialty additives used across various sectors. The company serves diverse markets such as pharmaceuticals, animal nutrition, glass, ceramics, and industrial manufacturing. Omkar Speciality Chemicals emphasizes research and development to maintain high purity standards and process efficiency. Its operations involve complex chemical synthesis and the development of customized solutions to meet specific client requirements in the global chemical supply chain.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 85% confidence The document is a notice to stock exchanges under SEBI LODR Regulation 29 informing of an upcoming meeting of the Monitoring Committee. It is not the actual financial statements, not an earnings release, not a full report, nor a voting result, nor a direct appointment announcement. It is a routine regulatory disclosure/meeting notice. Within the provided taxonomy, there is no specific code for a Board Meeting Intimation, so this falls into the fallback category “Regulatory Filings” (RNS).
2026-05-22 English
Omkar Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Intimation of the ....
Regulatory Filings Classification · 85% confidence The document is a formal intimation to stock exchanges (BSE and NSE) under SEBI Listing Regulations (Regulation 29) notifying a forthcoming Monitoring Committee meeting. It does not contain actual financial statements, call transcript, dividend notice, or the decisions themselves—it is a regulatory announcement/notice of meeting. It falls under general regulatory filings rather than a specific report type or financial data. Therefore, it is best classified as a Regulatory Filing (RNS).
2026-05-22 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding a broad step plan for capital reduction, issuance and allotment of shares to a resolution applicant, and achieving minimum public shareholding. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and details procedural steps including capital reduction, share issuance, and public shareholding targets. The document is a formal announcement of planned corporate actions related to capital structure and shareholding, not a financial report or detailed financial statements. It is also relatively short (3527 characters) and serves as an update or notification rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP).
2026-04-28 English
Appointment
Board/Management Information Classification · 95% confidence The document is a detailed disclosure letter addressed to stock exchanges (BSE and NSE) regarding multiple corporate actions and approvals by the Monitoring Committee of Omkar Speciality Chemicals Limited. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and includes specifics such as: 1) Record date for extinguishment/cancellation of shares pursuant to a Resolution Plan approved by the National Company Law Tribunal (NCLT), 2) Issuance of equity shares on a private placement basis, 3) Borrowing by way of loan, 4) Treatment of earnest money deposit as debt/loan, 5) Appointment of a new Chief Financial Officer, and 6) Appointment of a whole-time company secretary and compliance officer. The document includes annexures with detailed information about the share issuance and appointments. The key focus is on announcements of changes in management and capital structure (share issuance and loan borrowing). The document is not a financial report, earnings release, or audit report. It is not a proxy or voting result announcement. It is a regulatory disclosure of corporate actions and appointments. Therefore, the most appropriate classification is "Board/Management Information (MANG)" because it announces appointments of key managerial personnel and significant corporate actions approved by the Monitoring Committee. Confidence is high given the detailed nature and regulatory references.
2026-04-15 English
Appointment
Capital/Financing Update Classification · 95% confidence The document is a detailed disclosure letter addressed to stock exchanges (BSE and NSE) regarding multiple corporate actions by Omkar Speciality Chemicals Limited. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and includes several key announcements: (1) record date for extinguishment/cancellation of shares pursuant to a resolution plan approved by the National Company Law Tribunal (NCLT), (2) issuance of equity shares on a private placement basis, (3) borrowing by way of loan, (4) treatment of earnest money deposit as debt/loan, (5) appointment of a new Chief Financial Officer, and (6) appointment of a whole-time company secretary and compliance officer. The document includes annexures with detailed information about the share issuance and appointments. The primary content is about changes in capital structure (share issuance and extinguishment) and appointments of key managerial personnel. The document is not a financial report, earnings release, or audit report. It is not a proxy or voting result announcement. It is not a merger or acquisition filing. The document is a regulatory announcement of multiple corporate actions including capital changes and management appointments. Given the multiple topics, the best fitting category is Capital/Financing Update (CAP) because the main focus is on share extinguishment, new share issuance, and loan borrowing, which are capital structure changes. The appointments of CFO and company secretary are secondary but support the capital restructuring context. The document is detailed and substantive, not a brief announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the classification is CAP with high confidence.
2026-04-15 English
Record Date
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding the record date for extinguishment/cancellation of paid-up share capital held by existing promoters and public shareholders. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and mentions a resolution plan approved by the National Company Law Tribunal (NCLT). The content is an official announcement about a corporate action related to share capital cancellation, not a full financial report or detailed management discussion. The document length is 3573 characters, which is relatively short and focused on a specific regulatory disclosure. This fits best with the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-04-15 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.